Biology and Adjunctive Treatments – for Medical Students
Options for Patients with Advanced Obesity or Weight-Related Comorbidities
1 hr(s) CME/CE
Goal: Learn to determine which patients meet criteria for prescribing FDA-approved weight-loss medications and how to safely prescribe, as well as how to select, advise, refer qualifying adult obese patients for weight-loss surgery and provide appropriate follow-up.
This activity is designed to change: Competence, Performance, Patient Outcome. 1 hr(s)
Professional Practice Gaps
After completing this activity participants will be able to:
- Explain the biological modifications that occur in chronic obesity that contribute to perpetuating the condition
- Describe the biological pathways and hormones involved in regulating appetite and weight
- Identify which patients meet guideline criteria for prescribing weight-loss medication as an adjunct to routine weight management
- Educate patients on the need for comprehensive weight-loss treatment in conjunction with weight-loss medication
- If prescribing FDA-approved weight-loss medications, select medications for individual patients based on the each medication’s pharmacological profile
- Discuss the potential side effects and effectiveness of FDA-approved weight-loss medications with patients
- Identify patients who meet criteria to be considered as candidates for bariatric surgery.
- Explain the advantages/disadvantages of different types of bariatric surgery for patients.
- Counsel patients regarding the behavioral, diet, and medication requirements following bariatric surgery.
- Provide appropriate medical management, as needed, for patients who have had bariatric surgery.
- Describe the newer devices that are being developed for weight loss, many of which are inserted via endoscopy.
Modules in this Training Activity
Training Activity References
Audience and Accreditation
Audience: Healthcare providers, healthcare students
A letter of completion for 1 hours is available for non-physicians.
A score of 70% on the post-test is required to complete the activity.
Initial development of this activity was supported by a grant from the National Institute of Diabetes and Digestive and Kidney Diseases (#2R44DK091144-01A1) and NIDDK (#4R44DK108608-02).